Selecting medications for the treatment of urinary incontinence.
暂无分享,去创建一个
[1] A. Diokno,et al. Ephedrine in treatment of urinary incontinence. , 1975, Urology.
[2] J. Wyman,et al. Bladder training in ambulatory care management of urinary incontinence. , 1991, Urologic nursing.
[3] D. McClish,et al. Estrogen Therapy in the Management of Urinary Incontinence in Postmenopausal Women: A Meta-Analysis. First Report of the Hormones and Urogenital Therapy Committee , 1994, Obstetrics and gynecology.
[4] D. McClish,et al. Efficacy of Estrogen Supplementation in the Treatment of Urinary Incontinence , 1996, Obstetrics and gynecology.
[5] J. Hruschak. Urinary Incontinence in Adults: Acute and Chronic Management , 1996 .
[6] P. Goode,et al. Pharmacologic treatment of lower urinary tract dysfunction in geriatric patients. , 1997, The American journal of the medical sciences.
[7] David H. Thom. Variation in Estimates of Urinary Incontinence Prevalence in the Community: Effects of Differences in Definition, Population Characteristics, and Study Type , 1998 .
[8] T. Wagner,et al. Economic costs of urinary incontinence in 1995. , 1998, Urology.
[9] N. Resnick. Improving treatment of urinary incontinence. , 1998, JAMA.
[10] D. Lekan-Rutledge. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. , 1999, Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society.
[11] M. Elhilali,et al. Long–Term Effectiveness of Sacral Nerve Stimulation for Refractory Urge Incontinence , 2000, European Urology.
[12] P. Sand,et al. Update on extracorporeal magnetic innervation (EXMI) therapy for stress urinary incontinence. , 2000, Urology.
[13] P. Goode,et al. Combined Behavioral and Drug Therapy for Urge Incontinence in Older Women , 2000, Journal of the American Geriatrics Society.
[14] R. Dmochowski,et al. Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study. , 2001, Mayo Clinic proceedings.
[15] A. Wein,et al. Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. , 2001, Urology.
[16] M. Harvey,et al. Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta-analysis. , 2001, American journal of obstetrics and gynecology.
[17] J. Blonski. Is tolterodine (Detrol) or oxybutynin (Ditropan) the best for treatment of urge urinary incontinence? , 2001, The Journal of family practice.
[18] W. Dimpfel,et al. Effects of Tolterodine, Trospium Chloride, and Oxybutynin on the Central Nervous System , 2001, Journal of clinical pharmacology.
[19] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[20] D. Roth,et al. Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial. , 2002, JAMA.
[21] P. Herbison,et al. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. , 2002, The Cochrane database of systematic reviews.
[22] G. Webster,et al. Sacral neuromodulation in an older, urge-incontinent population. , 2002, American journal of obstetrics and gynecology.
[23] M. Detke,et al. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. , 2002, The Journal of clinical psychiatry.
[24] R. Dmochowski,et al. Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence. , 2002, The Journal of urology.
[25] P. Norton,et al. Duloxetine versus placebo in the treatment of stress urinary incontinence. , 2002, American journal of obstetrics and gynecology.
[26] R. Wallace,et al. Urinary Incontinence and Depression in Middle‐Aged United States Women , 2003, Obstetrics and gynecology.
[27] R. Dmochowski,et al. Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. , 2003, Mayo Clinic proceedings.
[28] R. Dmochowski,et al. Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence. , 2003, Urology.
[29] Oxybutynin transdermal (Oxytrol) for overactive bladder. , 2003, The Medical letter on drugs and therapeutics.
[30] R. Dmochowski,et al. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. , 2003, The Journal of urology.
[31] J. Ouslander,et al. Management of Overactive Bladder , 2004, CNS Spectrums.
[32] T. Wagner,et al. Economic costs of urinary incontinence , 2005, International Urogynecology Journal.